Clinical Trials Browser

Colorectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Biliary Tract Neoplasms

Sarcoma, Ewing

Solid Tumor Malignancy

Small Cell Lung Carcinoma

Glioblastoma

Pediatric Solid Tumors

Colorectal Adenocarcinoma Metastatic to the Liver

Biliary Tract Neoplasms, Gallbladder Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Colonic Neoplasms, Rectal Neoplasms

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Clinical Trials

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

SMMART Adaptive Clinical Treatment (ACT) Trial

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Selinexor Combination Ph 1 Study

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

IXO+A in mCRC With Liver-only Metastases

Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.